Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-activated inwardly rectifying potassium (GIRK) channels are a family of lipid-gated ion channels that play a fundamental role in regulating cellular excitability across the nervous system and the heart [1.1.1, 1.4.1]. These channels are primarily activated by the Gβγ subunits of inhibitory G proteins (Gi/o) following the stimulation of various G protein-coupled receptors (GPCRs), such as opioid, muscarinic M2, and GABA-B receptors [1.1.1, 1.4.3]. Upon activation, GIRK channels allow the efflux of potassium ions, leading to membrane hyperpolarization and a subsequent decrease in the firing rate of neurons or pacemaker cells [1.1.2, 1.4.1]. Dysregulation of GIRK channel activity is implicated in a wide range of pathologies, including epilepsy, chronic pain, drug addiction, and cardiac arrhythmias like atrial fibrillation [1.2.1, 1.2.2]. Consequently, they are viewed as promising therapeutic targets; activators are being explored for their anticonvulsant and analgesic properties, while selective blockers are under investigation for treating heart rhythm disorders [1.3.1, 1.4.4]. However, the development of GIRK-targeted therapies faces challenges related to subunit selectivity and the potential for off-target effects in the heart or brain [1.2.2, 1.4.5].
GIRK channels are activated by G-protein beta-gamma subunits following GPCR stimulation, leading to potassium efflux and membrane hyperpolarization, which inhibits cellular firing [1.1.1, 1.4.1].
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-activated inwardly rectifying potassium channel (GIRK) (GIRK).